Forecast to Publish a Funding Opportunity Announcement for Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Summary

The National Institutes of Health (NIH) is forecasting a Funding Opportunity Announcement (FOA) under the U24 cooperative agreement mechanism to provide sustained support for informatics technologies relevant to cancer research and management. The opportunity is designated as Clinical Trial Optional, meaning applicants may or may not propose clinical trials. This is a forecast notice only; the full FOA has not yet been published. The effort is expected to support the development, maintenance, and/or dissemination of informatics tools and infrastructure in support of cancer research and management activities.

What they want

How they evaluate

Risks & flags

• Forecast only — full FOA not yet published; scope, eligibility, and requirements are undefined at this stage.
• U24 cooperative agreement mechanism is typically awarded to established resource centers, which may favor incumbent or well-networked institutions.
• No response deadline, budget, or evaluation criteria disclosed; situational awareness is limited.